Stockscreener 앱 받기
2.86
4.35%
-0.13
시간 외 거래:
2.86
Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스
Lexeo stock hits 52-week low at $4.23 amid market challenges - MSN
Lexeo stock plunges to 52-week low at $3.42 amid market challenges By Investing.com - Investing.com South Africa
Lexeo stock plunges to 52-week low at $3.42 amid market challenges - Investing.com India
Lexeo Therapeutics CEO sells $19,090 in stock By Investing.com - Investing.com Nigeria
Lexeo Therapeutics chief medical officer sells $10,410 in stock By Investing.com - Investing.com Canada
Top Executives at Lexeo Therapeutics Cash In on Stock Sales! - TipRanks
Lexeo Therapeutics chief medical officer sells $10,410 in stock - Investing.com
Lexeo Therapeutics CEO sells $19,090 in stock - Investing.com India
Lexeo Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Lexeo Therapeutics CMO Sells Shares to Cover Tax Obligations - TradingView
SG Americas Securities LLC Makes New $72,000 Investment in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $23.80 Consensus Price Target from Brokerages - MarketBeat
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of “Buy” from Brokerages - Defense World
Market Recap: Lexeo Therapeutics Inc (LXEO)’s Negative Momentum, Closing at 4.95 - The Dwinnex
Lexeo Therapeutics Inc (LXEO) Stock: A Look at the Analyst Recommendations - The News Heater
BlackRock, Inc. Expands Holdings with Lexeo Therapeutics Inc. Ac - GuruFocus.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
JPMorgan Chase & Co. Boosts Holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
(LXEO) Trading Advice - Stock Traders Daily
Lexeo stock touches 52-week low at $4.76 amid market challenges - MSN
Leerink Partnrs Has Positive Outlook of LXEO FY2026 Earnings - Defense World
FY2026 EPS Estimate for Lexeo Therapeutics Raised by Analyst - MarketBeat
Lexeo Therapeutics’ (LXEO) Outperform Rating Reiterated at Royal Bank of Canada - Defense World
Royal Bank of Canada Reiterates Outperform Rating for Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat
Barclays PLC Acquires 31,057 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $23.80 Consensus Target Price from Analysts - MarketBeat
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Lexeo stock plunges to 52-week low, hits $5.75 amid market challenges - Investing.com Nigeria
How to Take Advantage of moves in (LXEO) - Stock Traders Daily
Jane Street Group LLC Buys 8,918 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Solid Biosciences stock jumps 11% post-market on FDA update - MSN
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Lexeo Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Geode Capital Management LLC Increases Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Geode Capital Management LLC Acquires 256,635 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat
Barclays PLC Buys 31,057 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Stake Raised by State Street Corp - Defense World
When (LXEO) Moves Investors should Listen - Stock Traders Daily
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
BNP Paribas Financial Markets Increases Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World
2.95%
0.31%
자본화:
|
볼륨(24시간):